clinical trial · NCT06906809
Effect of Phenytoin or Itraconazole on How BGB-16673 is Absorbed and Removed From the Body in Healthy Participants
BeiGene·phase1·completed·n = 37
Healthy VolunteersBGB-16673ItraconazolePhenytoin
brief summary
The purpose of this study is to investigate the effect of coadministration of phenytoin or itraconazole on the pharmacokinetics of BGB-16673 in healthy participants.
started
Apr 3, 2025
primary completion
Oct 13, 2025
completion
Oct 13, 2025
last updated
Nov 21, 2025
official title
A Phase 1, Open-label, Fixed-sequence, Crossover Study to Investigate the Effect of Coadministration of the CYP3A Inducer Phenytoin and the CYP3A Inhibitor Itraconazole on the Pharmacokinetics of BGB-16673 in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol